TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Vaccine Development Company Landscape Report 2025: Recent Expansions, Partnerships and Collaborations, Big Pharma Initiatives and Cost Price Analysis

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Researchandmarkets.Com
Vaccine Development Company Landscape Report 2025: Recent Expansions, Partnerships and Collaborations, Big Pharma Initiatives and Cost Price Analysis

The global vaccine development market is experiencing significant growth, with an estimated 7 billion doses produced in 2024 and expected 8 billion doses in 2025, driven by innovative technologies like mRNA vaccines and expansions in the Asia-Pacific region.

Insights
MRK   positive

Opened a $1 billion state-of-the-art vaccine manufacturing plant in North Carolina, demonstrating significant investment and technological advancement